Antonio Giordano, MD PhD (@antgiorda) 's Twitter Profile
Antonio Giordano, MD PhD

@antgiorda

Breast Medical Oncologist @harvardmed @DanaFarber driven by passion for #research and the one for taking care of #breastcancer patients #bcsm 🇮🇹🇺🇸

ID: 150297343

calendar_today31-05-2010 15:44:18

1,1K Tweet

3,3K Followers

1,1K Following

Dana-Farber’s Breast Oncology Center (@dfci_breastonc) 's Twitter Profile Photo

Dr. Hamilton (Erika Hamilton, MD) presents initial Phase 1 dose escalation data for Em-Le. The study concluded that "based on the initial reported data, Emi-Le appears to have encouraging clinical activity and tolerability in a heavily pretreated population." Antonio Giordano, MD PhD

Antonio Giordano, MD PhD (@antgiorda) 's Twitter Profile Photo

Emiltatug-ledadotin, B7-H4 ADC, auristatin💣DAR 6, dose escalation, showed activity in TNBC previously treated with Topo-1 ADC, and ACC-I #ASCO25 - TNBC ORR 23% (3/13) - ORR 🆙 with high B7-H4 - ACC-I ORR 56% (u+cPR) Trial expanding in TNBC 1-4L post ADC-top1 Dana-Farber’s Breast Oncology Center

Emiltatug-ledadotin, B7-H4 ADC, auristatin💣DAR 6, dose escalation, showed activity in TNBC previously treated with Topo-1 ADC, and ACC-I #ASCO25

- TNBC ORR 23% (3/13)
- ORR 🆙 with high B7-H4
- ACC-I ORR 56% (u+cPR)

Trial expanding in TNBC 1-4L post ADC-top1 <a href="/DFCI_BreastOnc/">Dana-Farber’s Breast Oncology Center</a>
Antonio Giordano, MD PhD (@antgiorda) 's Twitter Profile Photo

🔔Practice change alert for breast cancer physicians #bcsm ‼️Schedule your K522 and ascent-04 pts in the morning‼️ Randomized clinical trial shows improved OS…HR 0.45, for lung ca patients receiving NACT with immunotherapy in the morning #ASCO25 Harold J. Burstein, MD, PhD, FASCO

Antonio Giordano, MD PhD (@antgiorda) 's Twitter Profile Photo

Such an honor to have Dr. Beatrice Wiafe-Addai visiting Dana-Farber for few days. Interesting prospective of cancer care from 🇬🇭 Ghana where drug armamentarium is so limited. #cancerdisparity #westafrica Dana-Farber News Dana-Farber’s Breast Oncology Center

Such an honor to have Dr. Beatrice Wiafe-Addai visiting <a href="/DanaFarber/">Dana-Farber</a> for few days. Interesting prospective of cancer care from 🇬🇭 Ghana where drug armamentarium is so limited. #cancerdisparity #westafrica <a href="/DanaFarberNews/">Dana-Farber News</a> <a href="/DFCI_BreastOnc/">Dana-Farber’s Breast Oncology Center</a>
Raffaele Di Giacomo, PhD (@sciqst) 's Twitter Profile Photo

Antonio Giordano, MD PhD Dana-Farber Dana-Farber News Dana-Farber’s Breast Oncology Center Dr. Beatrice Wiafe-Addai's visit truly highlights the global challenges in cancer care, particularly in regions like Ghana where resource limitations pose significant hurdles. It raises important questions about how advancements in treatment can be equitably accessed worldwide.

THE SKIN DOCTOR (@theskindoctor13) 's Twitter Profile Photo

Pratik Joshi had been living in London for six years. A software professional, he’d long dreamed of building a life abroad for his wife and three young children, who stayed back in India. After years of waiting for due clearances the dream was finally coming true. Just two days

Pratik Joshi had been living in London for six years. A software professional, he’d long dreamed of building a life abroad for his wife and three young children, who stayed back in India.

After years of waiting for due clearances the dream was finally coming true. Just two days
Dana-Farber’s Breast Oncology Center (@dfci_breastonc) 's Twitter Profile Photo

Chemotherapy can save lives, but it can also come with challenges like #PeripheralNeuropathy. Ting Bao, MD, MS, (Ting Bao, MD) co-director of the Dana-Farber Zakim Center breaks down #ChemotherapyInducedPeripheralNeuropathy. Watch the webinar to learn about the causes, symptoms, risk

Chemotherapy can save lives, but it can also come with challenges like #PeripheralNeuropathy. Ting Bao, MD, MS, (<a href="/tingbao2011/">Ting Bao, MD</a>) co-director of the <a href="/DanaFarberZakim/">Dana-Farber Zakim Center</a> breaks down #ChemotherapyInducedPeripheralNeuropathy.  Watch the webinar to learn about the causes, symptoms, risk
Carmen Criscitiello (@carmencriscit) 's Twitter Profile Photo

📢 Just out in Cancer Treatment Reviews! We explore a key challenge in HR+/HER2– BC: resistance to CDK4/6i. 💡 Why it happens 🔄 How to overcome it with combos 🚀 What’s next Proud of the great collaborative effort behind this work. 📖 doi.org/10.1016/j.ctrv…

📢 Just out in Cancer Treatment Reviews!
We explore a key challenge in HR+/HER2– BC: resistance to CDK4/6i.
💡 Why it happens
🔄 How to overcome it with combos
🚀 What’s next
Proud of the great collaborative effort behind this work.
📖 doi.org/10.1016/j.ctrv…
Dr Sarah Sammons (@drsarahsam) 's Twitter Profile Photo

A nice patient friendly article on how metastases occur in breast cancer and how cells adapt to their metastatic environment. #bcsm knowablemagazine.org/content/articl…

A nice patient friendly article on how metastases occur in breast cancer and how cells adapt to their metastatic environment. 
#bcsm

knowablemagazine.org/content/articl…
Dana-Farber’s Breast Oncology Center (@dfci_breastonc) 's Twitter Profile Photo

Congratulations to Dr. Filipa Lynce (Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸) recipient of the Women’s Health Collaboration Award from the Massachusetts Life Sciences Center! This award supports collaborative projects that aim to improve the discovery, technical innovation, and analysis of datasets to answer pressing life

Congratulations to Dr. Filipa Lynce (<a href="/FilipaLynce/">Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸</a>) recipient of the Women’s Health Collaboration Award
from the <a href="/MALifeSciences/">Massachusetts Life Sciences Center</a>!  This award supports collaborative projects that aim to improve the discovery, technical innovation, and analysis of datasets to answer pressing life